Factor Viia Pages on BioPortfolio:

BAC and LFB Biotechnologies to Develop Custom Ligand for Purifying ...
28 May 2008 ... Working with LFB, BAC will discover and develop a custom CaptureSelect ligand for the purification of a recombinant Factor VIIa product – an ...
http://www.bioportfolio.com/biotech_news/BAC_6.htm...

BioPortfolio "coagulation factor IX (plasma thromboplastic ...
Matching: coagul factor ix plasma thromboplast compon christmas diseas hemophilia b .... Recombinant Human Antihemophilic Factor VIIa page 1 ...
http://www.bioportfolio.co.uk/antibody/coagulation%20factor%...

BioPortfolio - Factor Viia
Factor Viia - BioPortfolio - Indepth. ... PURPOSE: The use of factor VIIa (recombinant) for the treatment of acute... 21st August, 2008 ...
http://www.bioportfolio.com/indepth/Factor_Viia.html...

BioPortfolio.com - BioWeb VAGIFEM ESTRADIOL Search
Showing results 221-240 Search Journal Author Year Journal of Thrombosis and Haemostasis The role of recombinant factor VIIa(FVIIa) in fibrin structure in
...
http://www.bioportfolio.co.uk/VAGIFEM+ESTRADIOL-bioweb.htm...

BioPortfolio - Factor Viia
Factor Viia - BioPortfolio. ... Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of . ...
http://www.bioportfolio.com/search/Factor_Viia.html...

BioPortfolio - Factor Viia - InDepth
View the current Factor Viia InDepth page on BioPortfolio.com ... Low-dose recombinant factor VIIa for trauma patients with coagulopathy. ...
http://www.bioportfolio.com/indepth/Factor_Viia.pdf...

BioPortfolio - Novo Nordisk research
Mechanism of the Ca2+-induced enhancement of the intrinsic factor VIIa activity. The intrinsic activity of coagulation factor VIIa (FVIIa) is dependent on. ...
http://www.bioportfolio.com/biocorporate/7689-Novo%2BNordisk...

Factor Viia - B0008D8QM8 - Levent Filik
Factor Viia, 5.95, Search, BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and ...
http://www.bioportfolio.com/bookshop/Operation/ItemSearch/Se...

BioPortfolio - Factor Viia news
Factor Viia news - BioPortfolio - Indepth. ... Below is an extended Factor Viia news listing. Click here to return to the Factor Viia main in depth entry. ...
http://www.bioportfolio.com/indepth/Factor_Viia/news.html...

Recombinant factor VIIa for severe gastrointestinal hemorrhage ...
Recombinant factor VIIa for severe gastrointestinal hemorrhage associated with Crohn disease.(Editorial): An article from: Southern Medical Journal, 9.95, ...
http://www.bioportfolio.com/bookshop/ASIN/B000T907EQ/...

Results from other life science and pharmaceutical sites:

Recombinant Factor VIIa, Treatment of Hemophilia, Acute Bleeding ...
Created using Maxygen’s proprietary MolecularBreeding platform, MAXY-VII is a novel Factor VIIa for the treatment of hemophilia. ...
http://www.maxygen.com/products-hemostasis.php...

Recombinant factor VIIa. [Emerg Med Australas. 2004 Oct-Dec ...
Recombinant factor VIIa (rFVIIa, eptacog alfa, NovoSeven) is a ... Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in ...
http://www.ncbi.nlm.nih.gov/pubmed/15537408...

BioMed Central | Full text | Cost effectiveness of recombinant ...
Phase I/II placebo-controlled clinical trials of recombinant Factor VIIa (rFVIIa ) ... Recombinant factor VIIa (rFVIIa) is currently FDA-approved for the ...
http://www.biomedcentral.com/1471-2377/8/17...

Recombinant Factor VIIa
Recombinant Factor VIIa Stops Bleeding in Patients With Inhibitors to Clotting ... Recombinant factor VIIa is effective in the management of both bleeding ...
http://www.medscape.com/viewarticle/406393...

Recombinant Factor VIIa - Product Information - Novo Nordisk A/S
Factor VII/VIIa is a naturally ocurring protein found in the blood. ... NovoSeven® (recombinant human coagulation factor VIIa) has been developed by
Novo ...
http://www.novonordisk.com/therapy_areas/haemostasis/public/...

Factor VIIa (Recombinant) in Nonhemophiliac Patients After Cardiac ...
Factor VIIa (recombinant) is a vitamin K-dependent glycoprotein that works ... Factor VIIa (recombinant) received approved labeling from the Food and Drug ...
http://www.medscape.com/viewarticle/562419_2...

Use of human factor VIIa in the treatment of two hemophilia A ...
Upon treatment with Factor VIIa the circumference of the muscle decreased and joint mobility increased substantially. Patient 2 was given Factor VIIa ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=37...

Protocol for Factor VIIa Reduces Costs, Increases Off-Label Use
21 Feb 2007 ... Before the guidelines were implemented, dosing was often inappropriate; after the guidelines were implemented, more patients received fewer ...
http://www.medscape.com/viewarticle/552546...

Activation of factor VII bound to tissue factor: a key early step ...
Whether the factor VII/tissue factor complex that forms in tissue factor- dependent blood coagulation must be activated to factor VIIa/tissue factor
before ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=28...

Factor VIIa (Recombinant) in Nonhemophiliac Patients After Cardiac ...
While patients treated with factor VIIa (recombinant) had significantly ... Additional safety data for factor VIIa (recombinant) were published in 2006. ...
http://www.medscape.com/viewarticle/562419_4...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.